Fetal Bovine Serum Market Size, Share, Business Growth Industry Segment and Forecast till 2030.

The Fetal Bovine Serum Market was valued at USD 871.90 Million in 2021, registering a CAGR of 6.7 % during the forecast period (2022-2030), the market is projected to be worth USD 1,562.95 Million by 2030.

Fetal bovine serum (FBS) is a supplement commonly used in the culture of mammalian cells in laboratory settings. It is derived from the blood of unborn calves, and contains a wide range of nutrients, growth factors, and other molecules that are essential for the growth and survival of many types of cells.

FBS is used in a wide variety of research settings, including cell culture, tissue engineering, and the development of vaccines and therapeutics. It is also used in the production of biologics, such as monoclonal antibodies and recombinant proteins.

The market is projected to grow at a significant pace reaching a CAGR of approximately 6.7%, over the forecast period of 2022–2030, despite a considerable fall in product sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.

Segment:

By Application

· Biopharmaceuticals

· Human & Animal Vaccines

· Others

By End-use

· Biotechnology & Pharmaceutical Industries

· Academic Institutes

· Others

Key Players

· Gemini Bio-Products

· Bovogen Biologics Pty ltd.

· Thermo Fisher Scientific Inc.

· Merck KGaA

· GENERAL ELECTRIC

· Moregate Biotech

· Atlanta Biologics Inc.

Get Sample Report Here: https://marketresearchcommunity.com/sample-request/?rid=812

By Region

North America– (U.S., Canada, Mexico)

Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe)

Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific)

Latin America- (Brazil, Argentina, Chile, Rest of Latin America)

The Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA)

Geographically, the market is segmented into North America, Europe, Asia-Pacific, and the rest of the world. North America is the largest market for FBS, followed by Europe and Asia-Pacific. This is primarily due to the presence of a large number of biotechnology and biopharmaceutical companies in these regions.

The fetal bovine serum market Growth is driven by the growing demand for cell-based therapies, vaccines, and research in areas such as regenerative medicine and cancer. The use of FBS in the biopharmaceutical industry is also a major contributor to the growth of the market. Additionally, the growing demand for FBS in the production of diagnostic reagents, as well as in the bioprocessing of recombinant proteins, is also driving the market.

Contact:

Market Research Community

sales@marketresearchcommunity.com

Contact no.: (US) +1-214-272-039

(UK) +44-20-8133-9198